Publicacións en colaboración con investigadores/as de Karolinska University Hospital (12)

2022

  1. A 2B adenosine receptor antagonists rescue lymphocyte activity in adenosine-producing patient-derived cancer models

    Journal for ImmunoTherapy of Cancer, Vol. 10, Núm. 5

  2. COVID-19-specific metabolic imprint yields insights into multiorgan system perturbations

    European Journal of Immunology, Vol. 52, Núm. 3, pp. 503-510

  3. Immunodeficiency syndromes differentially impact the functional profile of SARS-CoV-2-specific T cells elicited by mRNA vaccination

    Immunity, Vol. 55, Núm. 9, pp. 1732-1746.e5

  4. NK cell frequencies, function and correlates to vaccine outcome in BNT162b2 mRNA anti-SARS-CoV-2 vaccinated healthy and immunocompromised individuals

    Molecular Medicine, Vol. 28, Núm. 1

  5. The Karolinska KI/K COVID-19 immune atlas: An open resource for immunological research and educational purposes

    Scandinavian Journal of Immunology, Vol. 96, Núm. 1

2021

  1. Deciphering the ins and outs of SARS-CoV-2-specific T cells

    Nature Immunology

  2. SARS-CoV-2-specific humoral and cellular immunity persists through 9 months irrespective of COVID-19 severity at hospitalisation

    Clinical and Translational Immunology, Vol. 10, Núm. 7

2020

  1. MAIT cell activation and dynamics associated with COVID-19 disease severity

    Science Immunology, Vol. 5, Núm. 51

  2. Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19

    Cell, Vol. 183, Núm. 1, pp. 158-168.e14

  3. TOX is expressed by exhausted and polyfunctional human effector memory CD8+ T cells

    Science Immunology, Vol. 5, Núm. 49

  4. The Identity of Human Tissue-Emigrant CD8+ T Cells

    Cell, Vol. 183, Núm. 7, pp. 1946-1961.e15

2019

  1. Tracking stem cells and macrophages with gold and iron oxide nanoparticles – The choice of the best suited particles

    Applied Materials Today, Vol. 15, pp. 267-279